Exact Sciences Corporation (EXAS)
Mar 23, 2026 - EXAS was delisted (reason: acquired by ABT)
104.91
+0.99 (0.95%)
Inactive · Last trade price on Mar 20, 2026
Exact Sciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -207.95 | -1,029 | -204.15 | -623.51 | -595.63 |
Depreciation & Amortization | 124.88 | 119.7 | 114.45 | 100.11 | 85.35 |
Stock-Based Compensation | 217.67 | 214.89 | 231.31 | 206.82 | 253.06 |
Other Adjustments | 235.02 | 960.82 | 14.85 | 119.39 | 43.87 |
Change in Receivables | -48.89 | -46.26 | -43.42 | 61.09 | 25.15 |
Changes in Inventories | -3.77 | -34.91 | -7.69 | -13.23 | -9.22 |
Changes in Accounts Payable | 214.04 | 43.54 | 82.75 | -52.18 | 169.8 |
Changes in Other Operating Activities | -39.55 | -18.38 | -31.99 | -22.05 | -74.62 |
Operating Cash Flow | 491.44 | 210.54 | 156.12 | -223.56 | -102.24 |
Operating Cash Flow Growth | 133.42% | 34.86% | - | - | - |
Capital Expenditures | -134.66 | -135.99 | -124.19 | -214.46 | -135.77 |
Sale of Property, Plant & Equipment | - | - | - | 25 | - |
Purchases of Investments | -195.77 | -466.76 | -156.42 | -174.31 | -1,182 |
Proceeds from Sale of Investments | 572.28 | 205.82 | 363.16 | 453.07 | 794.32 |
Cash Acquisitions | -75 | -45 | -52.91 | -14.69 | -557.8 |
Other Investing Activities | 28.27 | -0.23 | 20.04 | -0.55 | -0.74 |
Investing Cash Flow | 195.12 | -442.16 | 49.68 | 74.07 | -1,082 |
Short-Term Debt Issued | - | - | - | 50 | - |
Short-Term Debt Repaid | - | -50 | - | - | - |
Net Short-Term Debt Issued (Repaid) | - | -50 | - | 50 | - |
Long-Term Debt Issued | - | 266.75 | 137.98 | - | - |
Long-Term Debt Repaid | -249.17 | - | - | - | -23.75 |
Net Long-Term Debt Issued (Repaid) | -249.17 | 266.75 | 137.98 | - | -23.75 |
Issuance of Common Stock | 28.45 | 32.88 | 31.54 | 32.02 | 37.51 |
Net Common Stock Issued (Repurchased) | 28.45 | 32.88 | 31.54 | 32.02 | 37.51 |
Other Financing Activities | -117.36 | -17.75 | -9.75 | -5.53 | -5.29 |
Financing Cash Flow | -338.09 | 231.87 | 159.77 | 76.49 | 8.47 |
Foreign Exchange Rate Adjustments | 0.89 | -3.29 | 1.32 | 0.03 | 0.02 |
Net Cash Flow | 349.36 | -3.04 | 366.89 | -72.98 | -1,176 |
Free Cash Flow | 356.78 | 74.55 | 31.93 | -438.02 | -238 |
Free Cash Flow Growth | 378.60% | 133.48% | - | - | - |
FCF Margin | 10.99% | 2.70% | 1.28% | -21.02% | -13.47% |
Free Cash Flow Per Share | 1.89 | 0.40 | 0.18 | -2.48 | -1.39 |
Levered Free Cash Flow | -296.18 | -838.15 | -32.84 | -775.33 | -583.84 |
Unlevered Free Cash Flow | -41.25 | -1,082 | -179.12 | -803.83 | -1,071 |